Preclinical toxicity studies of naltrexone.
D000284:Administration, Oral; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D003092:Colitis / Q000139:chemically induced; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004353:Drug Evaluation, Preclinical; D005260:Female; D005298:Fertility / Q000187:drug effects; D000882:Haplorhini; D007279:Injections, Subcutaneous; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D009270:Naloxone / Q000031:analogs & derivatives*; D009271:Naltrexone / Q000008:administration & dosage / Q000633:toxicity*; D051381:Rats; D012098:Reproduction / Q000187:drug effects; D012220:Rhinitis / Q000139:chemically induced; D013723:Teratogens
D013723:Teratogens; D009270:Naloxone; D009271:Naltrexone